eLife, 2023 · DOI: https://doi.org/10.7554/eLife.82938 · Published: April 14, 2023
Nerve cells in the brain and spinal cord are surrounded by a layer of insulation called myelin that allows cells to transmit messages to each other more quickly and efficiently. This protective sheath is produced by cells called oligodendrocytes which together with their immature counterparts can also repair damage caused to myelin. Recently it was discovered that mature and immature oligodendrocytes (which are collectively known as oligodendroglia) sometimes express proteins normally restricted to the immune system called major histocompatibility complexes (or MHCs for short). Researchers believe that MHC expression may allow oligodendroglia to interact with immune cells, potentially leading to the removal of oligodendroglia by the immune system as well as inflammation that exacerbates damage to nerves and hinders myelin repair. To address this, Harrington, Catenacci et al. created a genetically engineered mouse model in which the MHC-expressing oligodendroglia also generated a red fluorescent protein that could be detected under a microscope. This revealed that only a small number of oligodendroglia in the nervous system had MHCs, but these cells were located in areas of the brain and spinal cord with the highest inflammatory activity.
The frequency of immune oligodendroglia correlated with disease severity, suggesting a relationship with behavioral presentation that could be used to track the progression and treatment of demyelinating disease.
Identifying the phenotypic changes exhibited by cells with activated MHC pathways will help define the phenotypic changes they exhibit in diverse disease and injury contexts, and provide new insight into the complex cellular interactions that modify disease progression and repair.
These reporter mice will facilitate analysis of neuronal MHC signaling in other injury and disease contexts, expanding our knowledge about the prevalence and impact of MHC signaling in the CNS.